News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

35,144 signal articles · 107 in last 24h · 178,660 total before filter · latest 1h ago

107last 24h

3127last 7d

512● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1821 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: CANFSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

GlobeNewswire2d agobullish

Can-Fite to Pursue Global Licensing and Strategic Partnerships at BIO-Europe 2026 Following Recent Clinical and Intellectual Property Milestones

CANF

GlobeNewswire6d agoneutral

Can-Fite Announces Eurasian Patent Allowance Supporting Piclidenoson Development and Commercialization in Lowe Syndrome

CANF

GlobeNewswire13d agoneutral

Can-Fite Presents Final Positive Data from Phase IIa Pancreatic Cancer Study of Namodenoson at ESMO 2026

CANF

GlobeNewswire60d agoneutral

Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation

CANF

GlobeNewswire61d agoneutral

Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study

CANF

Benzinga67d agoneutral

Can-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer Study

CANF

GlobeNewswire67d agoneutral

Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds

CANF

GlobeNewswire67d agoneutral

Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study

CANF

GlobeNewswire83d agoneutral

Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer

CANF

GlobeNewswire88d agoneutral

Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates

CANF

MT Newswires130d agoneutral

Sector Update: Healthcare Stocks Higher Late Afternoon

CANF HIMS

Zacks248d agobullish

CANF Stock Soars 20% on Positive Mid-Stage Pancreatic Cancer Data

CANF

MT Newswires317d agoneutral

Sector Update: Health Care Stocks Edge Higher Late Afternoon

CANF

MT Newswires317d agoneutral

Sector Update: Health Care Stocks Lower in Friday Afternoon Trading

CANF

MT Newswires317d agoneutral

Top Midday Stories: Nvidia-Groq Licensing Deal; Target Attracts Growing Interest From Toms Capital

CANF

MT Newswires355d agoneutral

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as Investors Await Clues on Fed's Interest Rate Cut

CANF